Design of the SALT Osteoporosis Study: a randomised pragmatic trial, to study a primary care screening and treatment program for the prevention of fractures in women aged 65 years or older

[1] Genant HK(1999)Interim report and recommendations of the World Health Organization task-force for osteoporosis Osteoporos Int 10 259-264

[2] Cooper C(1991)Which fractures are associated with low appendicular bone mass in elderly women? The study of osteoporotic fractures research group Ann Intern Med 115 837-842

[3] Poor G(2016)Current and future incidence and costs of osteoporosis-related fractures in The Netherlands: combining claims data with BMD measurements Calcif Tissue Int 98 235-243

[4] Seeley DG(2005)Quality of life in patients with osteoporosis Osteoporos Int 16 447-455

[5] Browner WS(2013)Systematic review and meta-analysis of the efficacy and safety of alendronate and zoledronate for the treatment of postmenopausal osteoporosis Gynecol Endocrinol 29 1005-1014

[6] Nevitt MC(2012)2012 update of French guidelines for the pharmacological treatment of postmenopausal osteoporosis Joint Bone Spine 79 304-313

[7] Genant HK(2013)Diagnosis and management of osteoporosis in postmenopausal women and older men in the UK: National Osteoporosis Guideline Group (NOGG) update 2013 Maturitas 75 392-396

[8] Scott JC(2012)NHG-Standaard Fractuurpreventie (tweede herziening) Huisarts Wet 55 452-458

[9] Cummings SR(2013)European guidance for the diagnosis and management of osteoporosis in postmenopausal women Osteoporos Int 24 23-57

[10] Lotters FJ(2013)2013 up-date of the consensus statement of the Spanish menopause society on postmenopausal osteoporosis Maturitas 76 99-107

[1] Genant HK(1999)Interim report and recommendations of the World Health Organization task-force for osteoporosis Osteoporos Int 10 259-264

[2] Cooper C(1991)Which fractures are associated with low appendicular bone mass in elderly women? The study of osteoporotic fractures research group Ann Intern Med 115 837-842

[3] Poor G(2016)Current and future incidence and costs of osteoporosis-related fractures in The Netherlands: combining claims data with BMD measurements Calcif Tissue Int 98 235-243

[4] Seeley DG(2005)Quality of life in patients with osteoporosis Osteoporos Int 16 447-455

[5] Browner WS(2013)Systematic review and meta-analysis of the efficacy and safety of alendronate and zoledronate for the treatment of postmenopausal osteoporosis Gynecol Endocrinol 29 1005-1014

[6] Nevitt MC(2012)2012 update of French guidelines for the pharmacological treatment of postmenopausal osteoporosis Joint Bone Spine 79 304-313

[7] Genant HK(2013)Diagnosis and management of osteoporosis in postmenopausal women and older men in the UK: National Osteoporosis Guideline Group (NOGG) update 2013 Maturitas 75 392-396

[8] Scott JC(2012)NHG-Standaard Fractuurpreventie (tweede herziening) Huisarts Wet 55 452-458

[9] Cummings SR(2013)European guidance for the diagnosis and management of osteoporosis in postmenopausal women Osteoporos Int 24 23-57

[10] Lotters FJ(2013)2013 up-date of the consensus statement of the Spanish menopause society on postmenopausal osteoporosis Maturitas 76 99-107